Joint Filing Agreement

Exhibit 1.1

Joint Filing Agreement

The undersigned hereby agree that this Schedule 13D (the “Schedule 13D”) with respect to the common stock of Senseonics Holdings, Inc. is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and that all subsequent amendments to the Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate. It is understood and agreed that the joint filing of the Schedule 13D shall not be construed as an admission that the persons named herein constitute a group for purposes of Regulation 13D-G of the Exchange Act, nor is a joint venture for purposes of the Investment Company Act of 1940.

Roche Holding Ltd
By:		/s/ Beat Kraehenmann
		Name:		Beat Kraehenmann
		Title:		Authorized Signatory
		Date:		June 9, 2017
By:		/s/ Andreas Knierzinger
		Name:		Andreas Knierzinger
		Title:		Authorized Signatory
		Date:		June 9, 2017
Roche Finance Ltd
By:		/s/ Beat Kraehenmann
		Name:		Beat Kraehenmann
		Title:		Authorized Signatory
		Date:		June 9, 2017
By:		/s/ Xxxxxx Xxxxxxxxxxxx
		Name:		Xxxxxx Xxxxxxxxxxxx
		Title:		Authorized Signatory
		Date:		June 9, 2017